Four more drug companies have settled allegations that they manipulated the Average Wholesale Price of their drugs, a practice that increases the amount that federal and state healthcare companies pay and enables drug companies to give doctors and pharmacies unlawful incentives in the form of extra profits.

Aventis, Bayer, Schering, and Pfizer will pay $49 million to Pennsylvania.  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb.  After the current settlements, Pennsylvania will have collected over $162.35 million.

Read the entire article, “Pfizer, Bayer others settle drug price allegations in Pa.”